Fusion Pharmaceuticals Organization
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals.
Estimated Revenue:
$1M to $10M
Technology:
Genetic Test & Molecular Diagnostics
Industry:
PharmTech
Investor Type:
Pharma Company
Last Funding Type:
Venture - Series Unknown
Total Funding:
$170.9M
Funding Status:
IPO
Headquarters:
Canada
Investors Number:
16
Founded Date:
2014
Employee Number:
11-50











%20.jpg)
